Just in time for the almost-gone stage 4 (Metavir) Heppers of my era, the VA is apparently snapping up Harvoni at $867 a pill. That’s down from the official price charged Multicare and Franciscan of $1187.00 each. The best news is everyone’s making it to the far shore (remission or SVR). In the latest trial results of 1A and 1B, Harvoni licked the plate. One fell out of the 20 in the first study to autoimmune issues. The second group of 20 lost none.
In what was always a harsh, debilitating battle against 1A and 1B, Heppers with it had to run the gauntlet with the hope, at best, of a 39% success rate using Interferon and Ribavirin. Nevertheless, VA doctors would tell you it was in the high 60s. Some went through the process again with no better results. Another member here did it three times with no luck. What…
View original post 567 more words